Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 39.6M | 47.5M | 28.3M | 882K |
| Cost of revenue | 1.2M | 783K | 456K | 17K |
| Gross profit | 38.4M | 46.8M | 27.8M | 865K |
| Operating expense | ||||
| Research & development | 15.1M | 23.4M | 20.2M | 30.8M |
| Selling general and admin | 40.0M | 43.4M | 35.9M | 39.4M |
| Other operating expenses | — | — | — | — |
| Operating income | -16.7M | -20.1M | -28.2M | -69.3M |
| Non operating interest income | ||||
| Income | 5.2M | 5.2M | 4.9M | 5.3M |
| Expense | 8.2M | 8.7M | 3.0M | 3.3M |
| Other income expense | -83K | -1.8M | -63K | -63K |
| Pretax income | -19.8M | -25.4M | -26.4M | -67.4M |
| Tax provision | — | — | — | — |
| Net income | -19.8M | -25.4M | -26.4M | -67.4M |
| Basic EPS | 0.0 | 0.0 | 0.0 | -0.1 |
| Diluted EPS | 0.0 | 0.0 | 0.0 | -0.1 |
| Basic average shares | 665.9M | 664.2M | 662.2M | 653.9M |
| Diluted average shares | 665.9M | 664.2M | 662.2M | 653.9M |
| EBITDA | -11.3M | -16.3M | -23.2M | -63.6M |
| Net income from continuing op. | -19.8M | -25.4M | -26.4M | -67.4M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |